DelMar Pharmaceuticals, Inc. 4
4 · DelMar Pharmaceuticals, Inc. · Filed Oct 5, 2016
Insider Transaction Report
Form 4
Mohr Erich
Director
Transactions
- Other
Common Stock
2016-10-03$3.20/sh+528$1,690→ 887 total
Footnotes (1)
- [F1]The shares were issued as dividends on the reporting person's shares of Series B Preferred Stock.